"Three-Person IVF" Update Reveals How Little We Know
By Jessica Cussins,
The Huffington Post
| 06. 05. 2014
Three-person IVF is a critical departure from the traditional kind. This new and biologically extreme technique, which has generated scientific and bioethical controversy on both sides of the Atlantic, would combine genetic material from one man and two women in a single embryo. It is currently prohibited in the United Kingdom, but has been heavily promoted by its developers, and the law could be changed as soon as this year to allow it to move into fertility clinics.
The technique under consideration is being proposed for women with a rare form of mitochondrial disease who wish to have an unaffected and mostly genetically related child. It requires the extraction of the nucleus from her egg or embryo followed by its reinsertion into another woman's egg or embryo. Any resulting child would inherit nuclear DNA from the intended mother and mitochondrial DNA from an anonymous egg provider.
The UK's fertility regulator, the Human Fertilisation and Embryology Authority (HFEA) has just released an update on the safety and efficacy of this "three-person IVF." The HFEA report will help inform the upcoming Parliamentary...
Related Articles
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
By Gemma Conroy, Nature | 06.27.2024
Image by Robina Weermeijer from Unsplash
A molecular-editing tool that’s small enough to be delivered to the brain shuts down the production of proteins that cause prion diseases, a rare but deadly group of neurodegenerative disorders.
The system — known...
By Mesha Maren , Salon | 07.20.2024
By Alcott Wei, South China Morning Post | 07.13.2024
China has banned all clinical research involving germline genome editing under a newly released ethics guideline.
Germline gene engineering relates to altering the DNA in sperm, eggs or early embryos to introduce changes that can be inherited.
“Any clinical research...